FindTrial
Sign In

OKSIKODONIN ANALGEETTINEN PITOISUUS PLASMASSA YHDESSÄ PARASETAMOLIN 1g TAI 2g IV KANSSA ANNETTUNA MAHAKIRURGISILLA POTILAILLA

OKSIKODONIN ANALGEETTINEN PITOISUUS PLASMASSA YHDESSÄ PARASETAMOLIN 1g TAI 2g IV KANSSA ANNETTUNA MAHAKIRURGISILLA POTILAILLA

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2007-000271-42-FI
Enrollment
Unknown
Registered
2007-02-06
Start date
2007-05-08
Completion date
Unknown
Last updated
2013-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tutkimukseen otetaan 24 sappileikkaukseen tulevaa perustervettä aikuispotilasta. MedDRA version: 9.1 Level: LLT Classification code 10017641 Term: Gallbladder disease

Interventions

Trade Name: Oxanest 10mg/ml, Leiras, Turku Pharmaceutical Form: Injection* INN or Proposed INN: OXYCODONE CAS Number: 76426 Trade Name: Perfalgan, Bristol-Myers Squibb, Bromma, Ruotsi Pharmaceutical

Sponsors

Matti Eskelinen
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Main Objective: ;Secondary Objective: ;Primary end point(s):—

Countries

Finland

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026